p53 and CyclinX D1 protein expression in carcinomas of the parotid gland

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1287-1290

  Pignataro, Lorenzo ^a,b   Capaccio, Pasquale ^a   Carboni, Nadia ^a   Pruneri, Giancarlo ^a   Ottaviani, Antonio ^a   Buffa, Roberto ^a   Broich, Guido ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Cyclin D1; Immunohistochemistry; p53; Salivary gland carcinoma

Indexed keywords

CYCLIN D1; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE G1 PHASE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PAROTID GLAND CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA; FEMALE; GENE EXPRESSION; GENES, BCL-1; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PAROTID NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0031802777     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Johns ME, and Goldsmith MM: Incidence, diagnosis, and classification of salivary gland tumors. Oncology 3: 47-56, 1989.
2. Johns ME, Kaplan MJ: Malignant neoplasms. In: Otolaryngology -Head and Neck Surgery (Cummings CW and Frederickson JE, eds), Ed. 2, St. Louis, pp. 1035-1069, 1994.
3. Spiro RH: Salivary neoplasms: overview of a 35 year experience with 2807 patients. Head Neck Surg 8: 177-184, 1986.
4. Kastan MB, Onkyekwear O, Sidransky D, Vogelstein B, Craig RW: participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
5. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J: Abnormal patterns of D-Type Cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
6. Vogelstein B, Kinzler K: p53 function and dysfunction. Cell 70: 523-526, 1992.
7. Chen X, Bargonetti J, Prives C: p53, through p21 (WAF1/CIP1) induces cyclin D1 synthesis. Cancer Res 55: 4257-4263, 1995.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancer. Science 253: 49-53, 1991.
9. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc700-p53 complex with an altered half-life. Mol Cell Biol 8: 531-539, 1988.
10. Motokura T, Blom T, Kim HG, Juppner H, Buderman JV, Kronenberg HM, Arnold A: A novel cyclin encoded by a bcl-1-linked candidate oncogene. Nature 350: 512-515, 1991.
11. Rosemberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, Arnold A: PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U.S.A. 88: 9638-9642, 1991.
12. Gillet C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54: 1812-1817, 1994.
13. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, Doi S, Santella RM, Weinstein IB: Amplification and expression of the human cyclin D gene in esophageal cancer. Oncogene 8: 3447-3457, 1993.
14. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A: PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinoma. Cancer Res 54: 4813-4817, 1994.
15. Fracchiolla NS, Pignataro L, Capaccio P, Trecca D, Boletini A, Ottaviani A, Polli E, Maiolo AT, Neri A: Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer 75: 1292-1301, 1995.
16. Zhang Y-J, Jiang W, Chen CJ, Lee LS, Kahn SM, Santella RM, Weinstein IB: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196: 1010-1016, 1993.
17. Bartkova J, Lukas J, Strauss M, Bartek J: Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10: 775-778, 1995.
18. Hellquist HB, Karlsson MG, Nilsson C: Salivary duct carcinoma - a highly aggressive salivary gland tumour with over expression of c-erbB-2. J Pathol 172: 35-44, 1994.
19. Righi PD, Li Y-Q, Deutsch M, McDonald JS, Wilson KM, Bejarano P, Stambrook PJ, Osterhage D, Nguyen C, Gluckman JL, Pavelic ZP: The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland. Anticancer Res 14: 2253 -2258, 1994.
20. Kamio N, Tanaka Y, Mukai M, Ikeda E, Kuramochi S, Fujii M, Hosoda Y: A hybrid carcinoma: adenoid cystic carcinoma and salivary duct carcinoma of the salivary gland. An immunohistochemical study. Virchows Arch 430: 495-500, 1997.
21. Li X, Tsuji T, Wen S, Mimura Y, Sasaki K, Shinozaki F: Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence In situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma Cancer 79: 2314-2319, 1997.
22. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E: p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 75(8): 2037-2044, 1995.
23. UICC: TNM classification of malignant tumours (Hermanek P and Sobin LH, eds), Berlin, Springer Verlag, 1987.
24. Fracchiolla NS, Pruneri G, Pignataro L, Carboni N, Capaccio P, Boletini A, Buffa R, Neri A: Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas. Correlation of protein expression with lymph node metastases and advanced clinical stage. Cancer 79: 1114-1121, 1997.
25. Pruneri G, Pignataro L, Fracchiolla NS, Ferrero S, Capaccio P, Carboni N, Ottaviani A, Maiolo AT, Neri A, Buffa R: p53 protein expression in laryngeal squamous cell carcinomas bearing wild-type and mutated p53 gene. Histopathology 28: 513-519, 1996.
26. Armitage P and Berry G: Statistical methods in medical research. Oxford, Blackwell Scientific Publications, 1991, pp 125-132.
27. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Ass 53: 457-481, 1958.
28. Capaccio P, Pruneri G, Carboni N, Pagliari AV, Buffa R, Neri A, Ottaviani A, Pignataro L: Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas. J Laryngol Otol 111: 622-626, 1997.
29. Michalides RJAM, van Veelen NMT, Kristel PMP, Hart AAM, Loftus BM, Hilgers FJM, Balm AJM: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 123: 497-502, 1997.
30. Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73: 728-734, 1996.
31. Johns III MM, Westra WH, Califano JA, Eisele D, Koch WM, Sidransky D: Allelotype of salivary gland tumors. Cancer Res 56: 1151-1154, 1996.
32. Kamio N: Coexpression of p53 and c-erbB-2 proteins is associated with histological types, tumour stage, and cell proliferation in malignant salivary gland tumours. Virchows Arch 428: 75-83, 1996.